1. Home
  2. LCTX vs IMXI Comparison

LCTX vs IMXI Comparison

Compare LCTX & IMXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LCTX
  • IMXI
  • Stock Information
  • Founded
  • LCTX 1990
  • IMXI 1994
  • Country
  • LCTX United States
  • IMXI United States
  • Employees
  • LCTX N/A
  • IMXI N/A
  • Industry
  • LCTX Biotechnology: Biological Products (No Diagnostic Substances)
  • IMXI Retail: Computer Software & Peripheral Equipment
  • Sector
  • LCTX Health Care
  • IMXI Technology
  • Exchange
  • LCTX Nasdaq
  • IMXI Nasdaq
  • Market Cap
  • LCTX 405.4M
  • IMXI 438.1M
  • IPO Year
  • LCTX N/A
  • IMXI N/A
  • Fundamental
  • Price
  • LCTX $1.76
  • IMXI $15.08
  • Analyst Decision
  • LCTX Strong Buy
  • IMXI Buy
  • Analyst Count
  • LCTX 4
  • IMXI 4
  • Target Price
  • LCTX $4.25
  • IMXI $17.50
  • AVG Volume (30 Days)
  • LCTX 2.6M
  • IMXI 297.6K
  • Earning Date
  • LCTX 11-06-2025
  • IMXI 11-10-2025
  • Dividend Yield
  • LCTX N/A
  • IMXI N/A
  • EPS Growth
  • LCTX N/A
  • IMXI N/A
  • EPS
  • LCTX N/A
  • IMXI 1.29
  • Revenue
  • LCTX $10,816,000.00
  • IMXI $625,123,000.00
  • Revenue This Year
  • LCTX N/A
  • IMXI N/A
  • Revenue Next Year
  • LCTX $176.00
  • IMXI $1.87
  • P/E Ratio
  • LCTX N/A
  • IMXI $11.70
  • Revenue Growth
  • LCTX 24.05
  • IMXI N/A
  • 52 Week Low
  • LCTX $0.37
  • IMXI $8.58
  • 52 Week High
  • LCTX $2.09
  • IMXI $22.30
  • Technical
  • Relative Strength Index (RSI)
  • LCTX 50.62
  • IMXI 63.61
  • Support Level
  • LCTX $1.77
  • IMXI $15.04
  • Resistance Level
  • LCTX $1.99
  • IMXI $15.20
  • Average True Range (ATR)
  • LCTX 0.15
  • IMXI 0.08
  • MACD
  • LCTX -0.01
  • IMXI -0.02
  • Stochastic Oscillator
  • LCTX 42.27
  • IMXI 67.95

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

About IMXI International Money Express Inc.

International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

Share on Social Networks: